aluates Reports

$ 0.0

Automative

Global Sexually Transmitted Diseases (STD) Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-13T6110

Global Sexually Transmitted Diseases STD Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Sexually Transmitted Diseases (STD) Treatment Market Research Report 2025

Code: QYRE-Auto-13T6110

Report

September 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Roche

Gilead Sciences

GlaxoSmithKline PLC

Johnson & Johnson

Merck

AbbVie

Bayer

Bristol–Myers Squibb

Eli Lilly

Johnson & Johnson

Sexually Transmitted Diseases (STD) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sexually Transmitted Diseases (STD) Treatment Market

The global market for Sexually Transmitted Diseases (STD) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Sexually transmitted diseases (STD), are infections that are commonly spread by sexual activity. Many times STD initially do not cause symptoms, this results in a greater risk of passing the disease on to others.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Treatment.

The Sexually Transmitted Diseases (STD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sexually Transmitted Diseases (STD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sexually Transmitted Diseases (STD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sexually Transmitted Diseases (STD) Treatment Market Report

Report Metric	Details
Report Name	Sexually Transmitted Diseases (STD) Treatment Market
CAGR	5%
Segment by Type	Viral Infections Bacterial Infections Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bayer, Bristol-Myers Squibb, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sexually Transmitted Diseases (STD) Treatment Market report?

Ans: The main players in the Sexually Transmitted Diseases (STD) Treatment Market are Pfizer, Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bayer, Bristol-Myers Squibb, Eli Lilly

What are the Application segmentation covered in the Sexually Transmitted Diseases (STD) Treatment Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases (STD) Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sexually Transmitted Diseases (STD) Treatment Market report?

Ans: The Types covered in the Sexually Transmitted Diseases (STD) Treatment Market report are Viral Infections, Bacterial Infections, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Viral Infections

1.2.3 Bacterial Infections

1.2.4 Others

1.3 Market by Application

1.3.1 Global Sexually Transmitted Diseases (STD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sexually Transmitted Diseases (STD) Treatment Market Perspective (2020-2031)

2.2 Global Sexually Transmitted Diseases (STD) Treatment Growth Trends by Region

2.2.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sexually Transmitted Diseases (STD) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Sexually Transmitted Diseases (STD) Treatment Market Dynamics

2.3.1 Sexually Transmitted Diseases (STD) Treatment Industry Trends

2.3.2 Sexually Transmitted Diseases (STD) Treatment Market Drivers

2.3.3 Sexually Transmitted Diseases (STD) Treatment Market Challenges

2.3.4 Sexually Transmitted Diseases (STD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sexually Transmitted Diseases (STD) Treatment Players by Revenue

3.1.1 Global Top Sexually Transmitted Diseases (STD) Treatment Players by Revenue (2020-2025)

3.1.2 Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Sexually Transmitted Diseases (STD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sexually Transmitted Diseases (STD) Treatment Revenue

3.4 Global Sexually Transmitted Diseases (STD) Treatment Market Concentration Ratio

3.4.1 Global Sexually Transmitted Diseases (STD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Treatment Revenue in 2024

3.5 Global Key Players of Sexually Transmitted Diseases (STD) Treatment Head office and Area Served

3.6 Global Key Players of Sexually Transmitted Diseases (STD) Treatment, Product and Application

3.7 Global Key Players of Sexually Transmitted Diseases (STD) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases (STD) Treatment Breakdown Data by Type

4.1 Global Sexually Transmitted Diseases (STD) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Type (2026-2031)

5 Sexually Transmitted Diseases (STD) Treatment Breakdown Data by Application

5.1 Global Sexually Transmitted Diseases (STD) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sexually Transmitted Diseases (STD) Treatment Market Size (2020-2031)

6.2 North America Sexually Transmitted Diseases (STD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025)

6.4 North America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sexually Transmitted Diseases (STD) Treatment Market Size (2020-2031)

7.2 Europe Sexually Transmitted Diseases (STD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025)

7.4 Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sexually Transmitted Diseases (STD) Treatment Market Size (2020-2031)

9.2 Latin America Sexually Transmitted Diseases (STD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025)

9.4 Latin America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Sexually Transmitted Diseases (STD) Treatment Introduction

11.1.4 Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Sexually Transmitted Diseases (STD) Treatment Introduction

11.2.4 Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Introduction

11.3.4 Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.3.5 Gilead Sciences Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Introduction

11.4.4 GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.4.5 GlaxoSmithKline Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Introduction

11.5.4 Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Sexually Transmitted Diseases (STD) Treatment Introduction

11.6.4 Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.6.5 Merck Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Sexually Transmitted Diseases (STD) Treatment Introduction

11.7.4 AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.7.5 AbbVie Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Sexually Transmitted Diseases (STD) Treatment Introduction

11.8.4 Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Introduction

11.9.4 Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 Eli Lilly

11.10.1 Eli Lilly Company Details

11.10.2 Eli Lilly Business Overview

11.10.3 Eli Lilly Sexually Transmitted Diseases (STD) Treatment Introduction

11.10.4 Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

11.10.5 Eli Lilly Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Roche

Gilead Sciences

GlaxoSmithKline PLC

Johnson & Johnson

Merck

AbbVie

Bayer

Bristol–Myers Squibb

Eli Lilly

Johnson & Johnson

List of Tables

Table 1. Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Viral Infections

Table 3. Key Players of Bacterial Infections

Table 4. Key Players of Others

Table 5. Global Sexually Transmitted Diseases (STD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Region (2020-2025)

Table 9. Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Region (2026-2031)

Table 11. Sexually Transmitted Diseases (STD) Treatment Market Trends

Table 12. Sexually Transmitted Diseases (STD) Treatment Market Drivers

Table 13. Sexually Transmitted Diseases (STD) Treatment Market Challenges

Table 14. Sexually Transmitted Diseases (STD) Treatment Market Restraints

Table 15. Global Sexually Transmitted Diseases (STD) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Players (2020-2025)

Table 17. Global Top Sexually Transmitted Diseases (STD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Treatment as of 2024)

Table 18. Ranking of Global Top Sexually Transmitted Diseases (STD) Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Sexually Transmitted Diseases (STD) Treatment, Headquarters and Area Served

Table 21. Global Key Players of Sexually Transmitted Diseases (STD) Treatment, Product and Application

Table 22. Global Key Players of Sexually Transmitted Diseases (STD) Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Sexually Transmitted Diseases (STD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Sexually Transmitted Diseases (STD) Treatment Product

Table 50. Pfizer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Sexually Transmitted Diseases (STD) Treatment Product

Table 55. Roche Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Gilead Sciences Company Details

Table 58. Gilead Sciences Business Overview

Table 59. Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Product

Table 60. Gilead Sciences Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 61. Gilead Sciences Recent Development

Table 62. GlaxoSmithKline Company Details

Table 63. GlaxoSmithKline Business Overview

Table 64. GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Product

Table 65. GlaxoSmithKline Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 66. GlaxoSmithKline Recent Development

Table 67. Johnson & Johnson Company Details

Table 68. Johnson & Johnson Business Overview

Table 69. Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Product

Table 70. Johnson & Johnson Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 71. Johnson & Johnson Recent Development

Table 72. Merck Company Details

Table 73. Merck Business Overview

Table 74. Merck Sexually Transmitted Diseases (STD) Treatment Product

Table 75. Merck Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 76. Merck Recent Development

Table 77. AbbVie Company Details

Table 78. AbbVie Business Overview

Table 79. AbbVie Sexually Transmitted Diseases (STD) Treatment Product

Table 80. AbbVie Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 81. AbbVie Recent Development

Table 82. Bayer Company Details

Table 83. Bayer Business Overview

Table 84. Bayer Sexually Transmitted Diseases (STD) Treatment Product

Table 85. Bayer Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 86. Bayer Recent Development

Table 87. Bristol-Myers Squibb Company Details

Table 88. Bristol-Myers Squibb Business Overview

Table 89. Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Product

Table 90. Bristol-Myers Squibb Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 91. Bristol-Myers Squibb Recent Development

Table 92. Eli Lilly Company Details

Table 93. Eli Lilly Business Overview

Table 94. Eli Lilly Sexually Transmitted Diseases (STD) Treatment Product

Table 95. Eli Lilly Revenue in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025) & (US$ Million)

Table 96. Eli Lilly Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Sexually Transmitted Diseases (STD) Treatment Picture

Figure 2. Global Sexually Transmitted Diseases (STD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Viral Infections Features

Figure 5. Bacterial Infections Features

Figure 6. Others Features

Figure 7. Global Sexually Transmitted Diseases (STD) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Sexually Transmitted Diseases (STD) Treatment Report Years Considered

Figure 13. Global Sexually Transmitted Diseases (STD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Sexually Transmitted Diseases (STD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Sexually Transmitted Diseases (STD) Treatment Market Share by Players in 2024

Figure 17. Global Top Sexually Transmitted Diseases (STD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Treatment Revenue in 2024

Figure 19. North America Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Sexually Transmitted Diseases (STD) Treatment Market Share by Country (2020-2031)

Figure 21. United States Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Sexually Transmitted Diseases (STD) Treatment Market Share by Country (2020-2031)

Figure 25. Germany Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Sexually Transmitted Diseases (STD) Treatment Market Share by Region (2020-2031)

Figure 33. China Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Sexually Transmitted Diseases (STD) Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Sexually Transmitted Diseases (STD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 50. Gilead Sciences Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 54. AbbVie Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 57. Eli Lilly Revenue Growth Rate in Sexually Transmitted Diseases (STD) Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sexually Transmitted Diseases STDs Testing Devices Market Research Report 2025

Global Sexually Transmitted Disease STD Testing Market Insights Forecast to 2030

Global STD Tests Market Research Report 2024

Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2030

Global Sexually Transmitted Disease Therapeutics Market Insights Forecast to 2030

Chlamydia Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sexually Transmitted Diseases Test Kit Market Research Report 2025

Global Sexually Transmitted Diseases Drug Market Research Report 2025

Global Diagnostic Testing For STDs Market Insights Forecast to 2030

Global Home Sexually Transmitted Diseases Test Kit Market Research Report 2025

STDs Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Syphilis Diagnosis Market Research Report 2024

Global Trachoma Treatments Market Research Report 2024

Global STD Testing Kits Market Research Report 2024

Genital Warts Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Std Self Diagnostics Market Research Report 2024

Global Chlamydia Infection Therapeutics Market Research Report 2024

Global Sex Products Market Research Report 2024

Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions